Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation, Mediated by the NLRP3 Inflammasome, in Patients After Cardiac Surgery

NCT04432337 is registered in ClinicalTrials.gov with University Hospital Center of Martinique as lead sponsor.

NCT NCT04432337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04432337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation, Mediated by the NLRP3 Inflammasome, in Patients After Cardiac Surgery
Lead sponsor
University Hospital Center of Martinique
Phase
Not applicable
Overall status
Withdrawn
Start date
January 1, 2021
Completion date
March 1, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, extracorporeal circulation; complications, inflammatory response, type 2 diabetes